作者
Malik E Juweid, Nidal J Rabadi, Mark Tulchinsky, Mohammed Aloqaily, Ahmad Al-Momani, Majd Arabiat, Gassem Abu Ain, Hussam Al Hawari, Munther Al-Momani, Ayman Mismar, Amr Abulaban, Ibrahim Taha, Abdullah Alhouri, Ayman Zayed, Nader Albsoul, Mousa A Al-Abbadi
发表日期
2021/9
期刊
Endocrine
卷号
73
页码范围
633-640
出版商
Springer US
简介
Objectives
The 2015 American Thyroid Association (ATA) guidelines called for significantly more selective 131I therapy in patients with low-risk differentiated thyroid cancer (DTC). We hypothesized that application of these guidelines would significantly reduce the 131I activity utilized by an academic tertiary hospital in Jordan.
Methods
All DTC patients managed at Jordan University Hospital (JUH) between 1/2009 and 6/2019 were classified according to the 2015 ATA risk category and 131I activity was assigned accordingly. The actual 131I activity administered was compared with that recommended by the 2015 ATA guidelines.
Results
In total, 135/182 DTC patients (74.2%) managed at JUH underwent 131I therapy. Of those, 58 (43%) had ATA low-, 58 (43%) intermediate-, and 19 (14%) high-risk disease. The low …
学术搜索中的文章
ME Juweid, NJ Rabadi, M Tulchinsky, M Aloqaily… - Endocrine, 2021